Shire Plc (SHP)-Medical Equipment-Deals and Alliances Profile

Shire Plc (SHP)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME40168D
  • |
  • Pages: 69
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases. The company primarily sells its products through pharmaceutical wholesale distributors and large pharmacies, in both the US and Europe. The company operates along with its subsidiaries and representative offices in Europe, the Americas, Asia Pacific, South Africa and other countries. Shire is headquartered in Dublin, Ireland.

Shire Plc (SHP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Shire Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Shire Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Shire Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Shire Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Shire Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Shire Plc, Medical Equipment, Deal Details 12

Venture Financing 12

Lotus Tissue Repair Secures US$26 Million In Series A Financing 12

DBV Technologies Secures US$25.5 Million In Series C Venture Financing Round 12

Partnerships 14

EM Imaging Enters into Licensing Agreement with GE Healthcare and Dyax 14

Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 15

Equity Offering 16

Dyax Completes Public Offering Of Shares For US$85 Million 16

Dyax Completes Public Offering Of Shares For US$69 Million 17

Dyax Completes Private Placement Of Preferred Stock For US$9.5 Million 18

Dyax Completes Private Placement Of Shares For US$20.5 Million 19

Debt Offering 21

Shire Raises USD3 Billion in Public Offering of 3.2% Notes Due 2026 21

Shire Raises USD3.3 Billion in Public Offering of 1.9% Notes Due 2019 22

Shire Raises USD3.3 Billion in Public Offering of 2.4% Notes Due 2021 24

Shire Raises USD2.5 Billion in Public Offering of 2.875% Notes Due 2023 26

Acquisition 27

Shire May Acquire Radius Health 27

Shire Acquires NPS Pharma for USD5.2 Billion 28

Shire Acquires Lotus Tissue Repair, Developer of Protein Replacement Therapy 30

Shire Completes Acquisition Of Advanced BioHealing 31

Shire Plc-Key Competitors 34

Key Employees 35

Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 45

Strategy And Business Planning 45

Apr 27, 2017: Shire opens new HQ office in Dublin City Centre 45

Dec 06, 2016: Planning permission granted for new Shire manufacturing site in Ireland 46

Nov 22, 2016: Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass. 47

Financial Announcements 48

May 02, 2017: Shire delivers strong Q1 2017 revenue growth while advancing late-stage pipeline 48

Feb 16, 2017: Shire Announces Full Year 2016 Results 52

Nov 01, 2016: Shire Reports Q3 2016 Results with Record Revenues and Reiterates Full Year Non GAAP Guidance 55

Aug 02, 2016: Shire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook 59

Corporate Communications 63

Jan 13, 2017: Shire Joins Illinois Biotechnology Innovation Organization as Leadership Sponsor and Adds Shannon Resetich to the Board 63

Jan 03, 2017: Shire Appoints Ian Clark as Non-Executive Director 64

Jun 07, 2016: Shire Announces Directorate change 65

Legal and Regulatory 66

Feb 07, 2017: Shire Responds to US Federal Trade Commission Civil Action 66

Jun 14, 2016: Shire Announces Additional Listing 67

Other Significant Developments 68

Jul 03, 2017: Shire Completes Combination with Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions 68

Appendix 69

Methodology 69

About GlobalData 69

Contact Us 69

Disclaimer 69

List of Figures

Shire Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Shire Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Shire Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Shire Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Shire Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Shire Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Shire Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Shire Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Shire Plc, Medical Equipment, Key Facts, 2016 1

Shire Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Shire Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Shire Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Shire Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Shire Plc, Deals By Market, 2011 to YTD 2017 9

Shire Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Lotus Tissue Repair Secures US$26 Million In Series A Financing 12

DBV Technologies Secures US$25.5 Million In Series C Venture Financing Round 12

EM Imaging Enters into Licensing Agreement with GE Healthcare and Dyax 14

Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 15

Dyax Completes Public Offering Of Shares For US$85 Million 16

Dyax Completes Public Offering Of Shares For US$69 Million 17

Dyax Completes Private Placement Of Preferred Stock For US$9.5 Million 18

Dyax Completes Private Placement Of Shares For US$20.5 Million 19

Shire Raises USD3 Billion in Public Offering of 3.2% Notes Due 2026 21

Shire Raises USD3.3 Billion in Public Offering of 1.9% Notes Due 2019 22

Shire Raises USD3.3 Billion in Public Offering of 2.4% Notes Due 2021 24

Shire Raises USD2.5 Billion in Public Offering of 2.875% Notes Due 2023 26

Shire May Acquire Radius Health 27

Shire Acquires NPS Pharma for USD5.2 Billion 28

Shire Acquires Lotus Tissue Repair, Developer of Protein Replacement Therapy 30

Shire Completes Acquisition Of Advanced BioHealing 31

Shire Plc, Key Competitors 34

Shire Plc, Key Employees 35

Shire Plc, Other Locations 36

Shire Plc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Shire Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16020
Site License
USD 500 INR 32040
Corporate User License
USD 750 INR 48060

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com